Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Recap: Alnylam Pharmaceuticals Q1 Earnings

 

Alnylam Pharmaceuticals (NASDAQ:ALNY) reported its Q1 earnings results on Thursday, April 28, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Alnylam Pharmaceuticals beat estimated earnings by 19.02%, reporting an EPS of $-1.49 versus an estimate of $-1.84.

Revenue was up $35.69 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.15 which was followed by a 0.07% drop in the share price the next day.

Here's a look at Alnylam Pharmaceuticals's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -1.54 -1.57 -1.6 -1.75
EPS Actual -1.69 -1.51 -1.3 -1.64
Revenue Estimate 233.62M 218.69M 193.18M 168.74M
Revenue Actual 258.54M 187.63M 220.55M 177.57M

To track all earnings releases for Alnylam Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.